American International Group, Inc. Protara Therapeutics, Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$8.68 - $16.99 $19,564 - $38,295	-2,254 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$13.75 - $23.86 $68 - $119	5 Added 0.22%	2,254 $35,000
Q4 2020 Feb 12, 2021	BUY	$16.97 - $25.34 $17,699 - $26,429	1,043 Added 86.48%	2,249 $54,000
Q3 2020 Nov 04, 2020	SELL	$16.76 - $31.89 $452 - $861	-27 Reduced 2.19%	1,206 $20,000
Q2 2020 Aug 12, 2020	BUY	$22.0 - $60.7 $27,126 - $74,843	1,233 New	1,233 $36,000

10.7M

1.8K

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $65.5M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.